Differential cardiovascular effects of nano- and micro-particles in mice: Implications for ultrafine and fine particle disease burden in humans

Andreas Daiber,Marin Kuntic,Ivana Kuntic,Dirk Cleppien,Andrea Pozzer,David Nußbaum,Matthias Oelze,Tristan Junglas,Lea Strohm,Henning Ubbens,Steffen Daub,Maria Teresa Bayo Jimenez,Sven Danckwardt,Thomas Berkemeier,Omar Hahad,Matthias Kohl,Sebastian Steven,Albrecht Stroh,Jos Lelieveld,Thomas Münzel

DOI: https://doi.org/10.26434/chemrxiv-2024-hhn4v

2024-10-10

Abstract:Particulate matter (PM) air pollution presents a major environmental and public health challenge because of its non-uniform size distribution and chemical composition. Air quality regulations generally categorize particulate matter (PM) size into PM10, PM2.5, and ultrafine particles (UFPs) with aerodynamic diameters < 10, 2.5, and 0.1 µm, respectively. We examined the differential impact of particle size per se on selected organ systems using a custom whole-body mouse exposure system using synthetic PM (SPM). The micrometer-sized SPM accumulated in the lungs as the primary entry organ, while ultrafine SPM showed less accumulation, implying a transition into circulation. Micro SPM-exposed mice exhibited inflammation and NADPH oxidase-derived oxidative stress in the lungs. Ultrafine SPM-exposed mice did not show oxidative stress in the lungs but rather at the brain, heart, and vasculature levels. Endothelial dysfunction and blood pressure increase were more pronounced in ultrafine SPM exposed mice, supported by increased endothelin-1 and decreased endothelial nitric oxide synthase expression, enhancing constriction and reducing vasodilation. To derive a preliminary estimate of the cardiovascular disease burden of UFPs in humans, we used new high-resolution exposure data at a global scale, and applied hazard ratios from an epidemiological cohort study. We derived a UFP-associated incidence of 419 (95% CI 78–712) thousand cardiovascular disease cases per year in the European Union and 5.6 (95% CI 1.1–9.3) million globally. This work provides novel insights into the different toxicological profiles of inhaled ultrafine particles and public health consequences of exposure, guiding future studies.

Chemistry

What problem does this paper attempt to address?

The paper aims to explore the effects of micron-sized and nano-sized particulate matter (PM) on different organ systems in mice, particularly whether these particles are more likely to penetrate the air-blood barrier and be detected in distal organs. Specifically, the study tracks the biodistribution of fluorescently labeled or magnetic nano-sized and micron-sized synthetic particles (SPM) to assess the impact of particles of different sizes on the function and molecular markers of the cardiovascular and pulmonary systems. Additionally, the study uses hazard ratios from the Dutch cohort study to estimate the impact of nanoparticles on the incidence of cardiovascular diseases in humans, highlighting the importance of nano-sized particles in disease outcomes. The research indicates that nano-sized particles are more likely than micron-sized particles to penetrate the lung epithelium and enter the bloodstream, affecting other distal organs such as the aorta, heart, and brain. Exposure to nanoparticles leads to impaired vascular function, manifested as increased blood pressure, decreased endothelium-dependent vasodilation, and increased oxidative stress. These effects may be mediated through multiple mechanisms, including direct damage and indirect vascular dysfunction induced by inflammatory responses. Furthermore, the study combines global ultrafine particle (UFP) exposure data with results from epidemiological cohort studies to preliminarily estimate the contribution of UFP to cardiovascular diseases in Europe and globally. In conclusion, the study reveals the different health impacts of nano-sized and micron-sized particles, emphasizing the potential hazards of nanoparticles in cardiovascular diseases and providing important evidence for future health risk assessments related to air pollution.

Differential cardiovascular effects of nano- and micro-particles in mice: Implications for ultrafine and fine particle disease burden in humans

STATE OF EPIDEMIOLOGICAL EVIDENCE FOR HEALTH IMPACTS OF ULTRAFINE PARTICLES

Co-exposure to urban particulate matter and aircraft noise adversely impacts the cerebro-pulmonary-cardiovascular axis in mice

The Biological Effects Upon the Cardiovascular System Consequent to Exposure to Particulates of Less Than 500 Nm in Size

Sub-micrometer Particulate Air Pollution and Cardiovascular Mortality in Beijing, China.

Label-free Detection and Quantification of Ultrafine Particulate Matter in Lung and Heart of Mouse and Evaluation of Tissue Injury.

Mechanistic insights into cardiovascular effects of ultrafine particle exposure: A longitudinal panel study

Beyond PM2.5: the Role of Ultrafine Particles on Adverse Health Effects of Air Pollution.

Short-Term Inhalation Exposure of Healthy and Compromised Rats and Mice to Fine and Ultrafine Carbon Particles

Pulmonary diseases induced by ambient ultrafine and engineered nanoparticles in twenty-first century

On the dose-response association of fine and ultrafine particles in an urban atmosphere: toxicological outcomes on bronchial cells at realistic doses of exposure at the Air Liquid Interface

Adverse effects of exposure to fine particles and ultrafine particles in the environment on different organs of organisms

Exposure to Ultrafine Particles and Respiratory Hospitalisations in Five European Cities

Respiratory effects of fine and ultrafine particles from indoor sources--a randomized sham-controlled exposure study of healthy volunteers

Exposure to ultrafine particles and respiratory hospitalizations in five European cities.

Short-term Exposure to Ultrafine Particles and Cardiovascular Hospitalizations: A Multicity Analysis.

Health Risk Assessment for Air Pollutants: Alterations in Lung and Cardiac Gene Expression in Mice Exposed to Milano Winter Fine Particulate Matter (PM2.5)

Short-term Exposure to Ultrafine Particulates and Whole Blood Transcriptome Analysis

Effects of Fine and Ultrafine Particles on Cardiorespiratory Symptoms in Elderly Subjects with Coronary Heart Disease: the ULTRA Study.

A systematic review about the relationship between human exposure to airborne particles and acute effect of cardiovascular disease

Intermittent Exposure to Airborne Particulate Matter Induces Subcellular Dysfunction and Aortic Cell Damage in BALB/c Mice Through Multi-Endpoint Assessment at Environmentally Relevant Concentrations.